SLC16A4 and cancer: All compoundsshowed functional inhibitory activities against MCT1 at low nanomolarconcentrations and great antiproliferative activities against theMCT1-expressing cancer cell lines A-549 and MCF-7, while the compoundswere selective over MCT4 (SLC16A4).